review Open AccessTop 1% cited
Axon degeneration in Parkinson's disease
Experimental Neurology · 2012 · Vol. 246 · pp. 72–83
Robert E. Burke✉(Columbia University)Karen L. O’Malley(Washington University in St. Louis)
Nerve injury and regenerationParkinson's Disease Mechanisms and TreatmentsSignaling Pathways in DiseaseNeuroscienceDegeneration (medical)NeuroprotectionAxonNeurodegenerationSomaDiseaseParkinson's diseaseBiologyMedicine
MeSH terms
AnimalsAxonsHumansNerve DegenerationParkinson Disease
Funding
- National Institutes of Health
Citations
493
FWCI
10.47
field-weighted impact
References
128
Percentile
99%
vs. same field & year
Citations per year
Cited by
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Frontiers in Neuroscience · 2018 · 359 citations
References
Parkinson's Disease
Neuron · 2003 · 5,394 citations
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Annals of Neurology · 2003 · 2,726 citations
Clinical progression in Parkinson disease and the neurobiology of axons
Annals of Neurology · 2010 · 1,012 citations
Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Journal of the Neurological Sciences · 1973 · 2,649 citations
mTOR regulation of autophagy
FEBS Letters · 2010 · 2,076 citations
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Acta Neuropathologica · 1988 · 519 citations
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Neuron · 2004 · 3,023 citations
A complex interplay between Akt, TSC2 and the two mTOR complexes
Biochemical Society Transactions · 2009 · 710 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.